Off-Label Drugs in Neonatology: Analyses Using Large Data Bases

Two reports in this volume of The Journal from the neonatology team at the University of North Carolina use the Pediatrix Medical Group Data Warehouse of administrative information to further the ongoing discussion of the frequent off-label uses of drugs in the neonatal intensive care unit (NICU).1,2 The report on the frequent, but not approved, use of furosemide for bronchopulmonary dysplasia (BPD) identified that prolonged use can decrease BPD.1 The report on surfactant for preterm infants with or at risk of respiratory distress syndrome (RDS) identified frequent deviations from the Food and Drug Administration (FDA) approved uses.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Editorial Source Type: research

Related Links:

Abstract Adult survivors of very preterm (≤32 weeks gestational age)birth without (PRE) and with bronchopulmonary dysplasia (BPD) have variable degrees of airflow obstruction at rest. Assessment of the shape of the maximal expiratory flow-volume (MEFV) curve in PRE and BPD may provide information concerning their unique pattern of airflow obstruction. The purposes of the present study were to: i) quantitatively assess the shape of the MEFV curve in PRE, BPD, and healthy adults born at full-term (CON), ii) identify where along the MEFV curve differences in shape existed between groups, and iii) determine the ass...
Source: American Journal of Physiology. Regulatory, Integrative and Comparative Physiology - Category: Physiology Authors: Tags: Am J Physiol Regul Integr Comp Physiol Source Type: research
CONCLUSIONS: Our study suggests that neonatal C57 mtDNA carrying strains have increased hyperoxia-induced hypoalveolarization, pulmonary mechanical dysfunction and mitochondrial bioenergetic and redox dysfunction vs. C3H mtDNA strains. Therefore, mtDNA haplogroup variation-induced differences in mitochondrial function could modify neonatal alveolar development and BPD susceptibility. PMID: 31432715 [PubMed - as supplied by publisher]
Source: American Journal of Physiology. Lung Cellular and Molecular Physiology - Category: Cytology Authors: Tags: Am J Physiol Lung Cell Mol Physiol Source Type: research
Condition:   Bronchopulmonary Dysplasia Intervention:   Combination Product: stem cell transplantation Sponsor:   Vinmec Research Institute of Stem Cell and Gene Technology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Journal of Perinatology, Published online: 20 August 2019; doi:10.1038/s41372-019-0458-yReply to: Transpyloric feeds and bronchopulmonary dysplasia
Source: Journal of Perinatology - Category: Perinatology & Neonatology Authors: Source Type: research
.
Source: Journal of Maternal-Fetal and Neonatal Medicine - Category: Perinatology & Neonatology Authors: Source Type: research
CONCLUSIONS In hyperoxia-induced rat models of BPD, hBD2 promotes alveolarization and improves pulmonary function. The mechanism may contribute in alleviating inflammation response and inhibiting pro-inflammatory factors including IL-1ß, IL-6, and TNF-alpha. PMID: 31411185 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Journal of Perinatology, Published online: 14 August 2019; doi:10.1038/s41372-019-0465-zTranspyloric feeds and bronchopulmonary dysplasia
Source: Journal of Perinatology - Category: Perinatology & Neonatology Authors: Source Type: research
AbstractBackgroundBronchopulmonary dysplasia (BPD) is the need for oxygen therapy at 36  weeks postmenstrual age (PMA). Sildenafil has been shown to enhance the lung alveolarization and vascularization in newborn animal models after lung injury and has possible therapeutic potential for the prevention of BPD.ObjectiveTo perform a proof-of-concept, Phase II, pilot randomized, double-blind, clinical trial to study the efficacy of sildenafil in preventing BPD, in postnatal (
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
Abstract Hyperoxia exposure in premature infants increases the risk of subsequent lung diseases such as asthma and bronchopulmonary dysplasia. Fibroblasts help maintain bronchial and alveolar integrity. Thus understanding mechanisms by which hyperoxia influences fibroblasts is critical. Cellular senescence is increasingly recognized as important to pathophysiology of multiple diseases. We hypothesized that clinically-relevant moderate hyperoxia (
Source: American Journal of Physiology. Lung Cellular and Molecular Physiology - Category: Cytology Authors: Tags: Am J Physiol Lung Cell Mol Physiol Source Type: research
.
Source: Journal of Maternal-Fetal and Neonatal Medicine - Category: Perinatology & Neonatology Authors: Source Type: research
More News: Bronchopulmonary Dysplasia | Food and Drug Administration (FDA) | Furosemide | Intensive Care | Pediatrics | Perinatology & Neonatology | Respiratory Medicine